Sanquin Research, Department of Immunopathology, and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, 1066 CX, Amsterdam, The Netherlands;
Sanquin Research, Department of Immunopathology, and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, 1066 CX, Amsterdam, The Netherlands.
Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1901-1906. doi: 10.1073/pnas.1711720115. Epub 2018 Feb 5.
A hallmark of B-cell immunity is the generation of a diverse repertoire of antibodies from a limited set of germline V(D)J genes. This repertoire is usually defined in terms of amino acid composition. However, variable domains may also acquire -linked glycans, a process conditional on the introduction of consensus amino acid motifs (-glycosylation sites) during somatic hypermutation. High levels of variable domain glycans have been associated with autoantibodies in rheumatoid arthritis, as well as certain follicular lymphomas. However, the role of these glycans in the humoral immune response remains poorly understood. Interestingly, studies have reported both positive and negative effects on antibody affinity. Our aim was to elucidate the role of variable domain glycans during antigen-specific antibody responses. By analyzing B-cell repertoires by next-generation sequencing, we demonstrate that -glycosylation sites are introduced at positions in which glycans can affect antigen binding as a result of a specific clustering of progenitor glycosylation sites in the germline sequences of variable domain genes. By analyzing multiple human monoclonal and polyclonal (auto)antibody responses, we subsequently show that this process is subject to selection during antigen-specific antibody responses, skewed toward IgG4, and positively contributes to antigen binding. Together, these results highlight a physiological role for variable domain glycosylation as an additional layer of antibody diversification that modulates antigen binding.
B 细胞免疫的一个标志是从有限的 germline V(D)J 基因中生成多样化的抗体库。该库通常根据氨基酸组成来定义。然而,可变区也可能获得 - 连接的聚糖,这个过程取决于在体细胞超突变过程中引入共识氨基酸模体(- 糖基化位点)。高水平的可变域糖基化与类风湿关节炎以及某些滤泡性淋巴瘤中的自身抗体有关。然而,这些糖基在体液免疫反应中的作用仍知之甚少。有趣的是,研究报告称这些糖基对抗体亲和力既有正面影响也有负面影响。我们的目的是阐明可变域糖基在抗原特异性抗体反应中的作用。通过下一代测序分析 B 细胞库,我们证明 - 糖基化位点是在糖基可以影响抗原结合的位置引入的,这是由于可变域基因的 germline 序列中前体糖基化位点的特定聚集。通过分析多个人类单克隆和多克隆(自身)抗体反应,我们随后表明,这个过程在抗原特异性抗体反应中受到选择,偏向 IgG4,并对抗原结合有积极贡献。总之,这些结果强调了可变域糖基化作为一种额外的抗体多样化层的生理作用,调节抗原结合。